Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration

The aim of this study was to establish the pharmacokinetics of levofloxacin (LVFX) and determine the optimal dose of this drug in critically ill patients receiving continuous hemodiafiltration (CHDF). The results of in vivo and in vitro studies showed the pharmacokinetics of LVFX total clearance (CL...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Intensive Care
Huvudupphovsmän: Wada, Takeshi, Kobayashi, Masaki, Ono, Yuichi, Mizugaki, Asumi, Katabami, Kenichi, Maekawa, Kunihiko, Miyamoto, Daisuke, Yanagida, Yuichiro, Hayakawa, Mineji, Sawamura, Atsushi, Iseki, Ken, Gando, Satoshi
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2015
Ämnen:
Letter to the Editor
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436099/
https://ncbi.nlm.nih.gov/pubmed/25992293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-015-0089-0
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk